Advanced Search

column
Theoretical Update of Cancer Evo-Dev and Its Role in Targeted Immunotherapy for Hepatocellular Carcinoma
CAO Guangwen
2022, 49(8): 747-755. DOI: 10.3971/j.issn.1000-8578.2022.22.0377
Abstract PDF
Exploration of Peritoneal Metastasis of Advanced Ovarian Cancer and Maintenance Treatment with Traditional Chinese Medicine Based on Theory of Membranous Sanjiao
LU Wenping
2022, 49(8): 756-759. DOI: 10.3971/j.issn.1000-8578.2022.22.0106
Abstract PDF
Negative Feedback Mechanism of Entero-gastric Inhibitory in Delayed Gastric Emptying Following Surgery for Stomach Cancer
TANG Wenhao
2022, 49(8): 760-763. DOI: 10.3971/j.issn.1000-8578.2022.21.1243
Abstract PDF
Evaluation and Current Clinical Progress of Invasiveness in Postoperative Residual Regrowth and Recurrence of Pituitary Adenoma
LEI Ting, WAN Xueyan, LIU Huiyong, LU Liang, CHEN Juan, SHU Kai
2022, 49(8): 764-768. DOI: 10.3971/j.issn.1000-8578.2022.21.1492
Abstract PDF
Influence of Changing Tendency in Sense of Head and Neck Carcinogenesis on Current Therapeutic Ideas and Its Clinical Implications
TIAN Daofa
2022, 49(8): 769-773. DOI: 10.3971/j.issn.1000-8578.2022.21.1428
Abstract PDF
Research Progress of Lipid Metabolism Reprogramming in Prostate Cancer
ZENG Kai, LIU Jihong, LI Qiang, WANG Qinzhang
2022, 49(8): 774-779. DOI: 10.3971/j.issn.1000-8578.2022.21.1546
Abstract PDF
Phototoxicity of Pheophorbide A Extracted from Gracilaria Lemaneiformis on Six Kinds of Cancer Cells
HUANG Xixiang, CAI Xiaoxuan, WANG Tianji, HUANG Miaoen, LI Li, LYU Yingnian
2022, 49(8): 780-785. DOI: 10.3971/j.issn.1000-8578.2022.22.0172
Abstract PDF
Risk of Recurrence or Metastasis of Breast Cancer by LNG-IUS: A Meta-analysis
WANG Ya'nan, LU Wenping, MEI Heting, CUI Yongjia, ZHUO Zhili
2022, 49(8): 786-791. DOI: 10.3971/j.issn.1000-8578.2022.21.1536
Abstract PDF
Expression and Clinical Significance of m6A Methylatransferase ZC3H13 in Gastric Cancer Tissues and Serum
JIA Lijuan, ZHANG Yunqiang, ZHANG Baihong, YUE Hongyun
2022, 49(8): 792-798. DOI: 10.3971/j.issn.1000-8578.2022.22.0039
Abstract PDF
A New N-staging System for Predicting Postoperative Survival of M0 Stage Inflammatory Breast Cancer
SUI Daxing, WANG Xueying, ZHANG Jiaxin
2022, 49(8): 799-805. DOI: 10.3971/j.issn.1000-8578.2022.21.1532
Abstract PDF
Incidence and Survival Trend of Malignant Tumors in Shenyang Urban Area from 2011 to 2018
LYU Yi, ZHANG Xinyu, ZHAO Xue, NIE Huifang, LI Xun
2022, 49(8): 806-811. DOI: 10.3971/j.issn.1000-8578.2022.21.1533
Abstract PDF
Advances in Treatment of Triple Negative Breast Cancer
KANG Yikun, YUAN Peng
2022, 49(8): 812-819. DOI: 10.3971/j.issn.1000-8578.2022.21.1323
Abstract PDF
Research Progress on Anti-Tumor Mechanism of Theaflavins Natural Products
ZHANG Xue, YIN Junli, WANG Jiaxiang, SHI Wengui, JIAO Zuoyi
2022, 49(8): 820-826. DOI: 10.3971/j.issn.1000-8578.2022.21.1292
Abstract PDF
Research Progress on Hyperthermia and Anti-Tumor Immunity
YIN Zhucheng, LIANG Xinjun
2022, 49(8): 827-831. DOI: 10.3971/j.issn.1000-8578.2022.22.0320
Abstract PDF
Anti-tumor Drug Delivery and Tumor Therapy Based on Metal-organic Frameworks
LI Bingtai, KOU Bangguo, JIANG Yongjie, BIAN Pan, YIN Lanning
2022, 49(8): 832-837. DOI: 10.3971/j.issn.1000-8578.2022.21.1457
Abstract PDF
Research Progress on Mechanism of Mitochondrial DNA in Occurrence and Development of Digestive System Malignant Tumors
WANG Lingxiao, WANG Yingjia, YANG Jian, LI Yaoping
2022, 49(8): 838-842. DOI: 10.3971/j.issn.1000-8578.2022.22.0542
Abstract PDF
Prognostic Value of Negative Lymph Nodes Count in Solid Tumors
LI Jinzhou, HUANG Zeping, MU Yanxi, YAO Yalong, WANG Wenjie, LIU Haipeng, LIU Jie, WANG Zhou, CHEN Xiao
2022, 49(8): 843-849. DOI: 10.3971/j.issn.1000-8578.2022.21.1523
Abstract PDF
Correlation Between STK11 Gene Mutation and Immunotherapy of Non-small Cell Lung Cancer
XIA Siyu, ZHAO Zitong, LI Li
2022, 49(8): 850-854. DOI: 10.3971/j.issn.1000-8578.2022.21.1133
Abstract PDF
Research Progress of Antibody-drug Conjugates in Advanced Non-small Cell Lung Cancer
CHEN Yarui, WANG Jiangtao, GUAN Quanlin, JI Wei, JIAO Fuzhi
2022, 49(8): 855-860. DOI: 10.3971/j.issn.1000-8578.2022.21.1466
Abstract PDF
Starch Supplementation can Reduce Risk of Hereditary Cancer in Lynch Syndrome Patients, etc.
2022, 49(8): 861-862. DOI: 10.3971/j.issn.1000-8578.2022.08.0001
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：